Acute eosinophilic pneumonia after changing dosing schedule of nivolumab

Jpn J Clin Oncol. 2021 Dec 1;51(12):1766-1767. doi: 10.1093/jjco/hyab130.

Authors

Kanako Shinada¹, Shuji Murakami¹, Hideyasu Sugimoto², Haruhiro Saito¹

Affiliations

¹ Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
² Department of Respiratory Medicine, Shonan Kamakura General Hospital, Kamakura, Japan.

PMID: 34345910
DOI: 10.1093/jjco/hyab130

No abstract available

Keywords: bronchoalveolar lavage; eosinophilic pneumonia; immune checkpoint inhibitor; malignant pleural mesothelioma; nivolumab.

MeSH terms

Humans
Mesothelioma*
Nivolumab / adverse effects
Pleural Neoplasms*
Pulmonary Eosinophilia* / chemically induced

Substances

Nivolumab